--- title: "12 Health Care Stocks Moving In Tuesday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/289969175.md" description: "In Tuesday's after-market session, several healthcare stocks saw significant movement. Lunai Bioworks surged 77.8% to $5.06, while 60 Degrees, MiNK Therapeutics, Processa Pharma, Redhill Biopharma, and SenesTech also posted gains. Conversely, NeOnc Technologies dropped 13.2%, CervoMed fell 11.73%, Neumora Therapeutics declined 10.26%, Aditxt plummeted 10.1%, TELA Bio decreased 9.69%, and Champions Oncology fell 6.25%. Market caps ranged from $3.9 million to $169.4 million." datetime: "2026-06-16T21:06:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289969175.md) - [en](https://longbridge.com/en/news/289969175.md) - [zh-HK](https://longbridge.com/zh-HK/news/289969175.md) --- # 12 Health Care Stocks Moving In Tuesday's After-Market Session ### Gainers - **Lunai Bioworks** (NASDAQ:LNAI) stock increased by 77.8% to $5.06 during Tuesday's after-market session. The company's market cap stands at $11.8 million. - **60 Degrees** (NASDAQ:SXTP) shares increased by 5.47% to $1.54. The market value of their outstanding shares is at $3.9 million. - **MiNK Therapeutics** (NASDAQ:INKT) shares moved upwards by 5.27% to $12.43. The company's market cap stands at $62.4 million. - **Processa Pharma** (NASDAQ:PCSA) shares increased by 5.26% to $2.2. The company's market cap stands at $6.0 million. - **Redhill Biopharma** (NASDAQ:RDHL) shares moved upwards by 5.25% to $0.83. The company's market cap stands at $4.3 million. - **SenesTech** (NASDAQ:SNES) stock moved upwards by 4.89% to $1.65. The company's market cap stands at $8.7 million. ### Losers - **NeOnc Technologies Hldgs** (NASDAQ:NTHI) stock decreased by 13.2% to $4.49 during Tuesday's after-market session. The company's market cap stands at $117.3 million. - **CervoMed** (NASDAQ:CRVO) stock declined by 11.73% to $3.99. The company's market cap stands at $22.9 million. - **Neumora Therapeutics** (NASDAQ:NMRA) shares fell 10.26% to $1.4. The market value of their outstanding shares is at $169.4 million. - **Aditxt** (NASDAQ:ADTX) stock fell 10.1% to $0.01. - **TELA Bio** (NASDAQ:TELA) stock decreased by 9.69% to $0.81. The company's market cap stands at $35.8 million. - **Champions Oncology** (NASDAQ:CSBR) stock declined by 6.25% to $6.45. The market value of their outstanding shares is at $88.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [NMRA.US](https://longbridge.com/en/quote/NMRA.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md) - [TELA.US](https://longbridge.com/en/quote/TELA.US.md) - [SNES.US](https://longbridge.com/en/quote/SNES.US.md) - [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md) - [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md) - [CRVO.US](https://longbridge.com/en/quote/CRVO.US.md) - [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md) - [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md) - [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md) - [INKT.US](https://longbridge.com/en/quote/INKT.US.md) - [CSBR.US](https://longbridge.com/en/quote/CSBR.US.md) - [RENB.US](https://longbridge.com/en/quote/RENB.US.md) ## Related News & Research - [Penny Stock Neumora Therapeutics Cuts Workforce After Depression Trials Fail](https://longbridge.com/en/news/289813061.md) - [Neumora Therapeutics scraps depression drug after two late-stage trial failures](https://longbridge.com/en/news/289781036.md) - [Cervo posts investor presentation on website covering clinical, development and financial updates](https://longbridge.com/en/news/289829022.md) - [60 Degrees Pharmaceuticals (NASDAQ:SXTP) CEO Geoffrey Dow Acquires 7,350 Shares](https://longbridge.com/en/news/289892370.md) - [Aditxt says DRW Securities files initial beneficial ownership statement showing 126,772 shares](https://longbridge.com/en/news/290097214.md)